Eyenovia

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Eyenovia and buy or sell other stocks, ETFs, and their options commission-free!

About EYEN

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. 

CEO
Michael M. Rowe
CEOMichael M. Rowe
Employees
14
Employees14
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2014
Founded2014
Employees
14
Employees14

EYEN Key Statistics

Market cap
4.78M
Market cap4.78M
Price-Earnings ratio
-0.32
Price-Earnings ratio-0.32
Dividend yield
Dividend yield
Average volume
8.57M
Average volume8.57M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$124.80
52 Week high$124.80
52 Week low
$0.85
52 Week low$0.85

People also own

Based on the portfolios of people who own EYEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.